Galsulfase (Intravenous Route)
Name: Galsulfase (Intravenous Route)
- Galsulfase Intravenous Route brand name
- Galsulfase Intravenous Route dosage
- Galsulfase Intravenous Route dosage forms
- Galsulfase Intravenous Route injection
- Galsulfase Intravenous Route used to treat
- Galsulfase Intravenous Route is used to treat
- Galsulfase Intravenous Route effects of
- Galsulfase Intravenous Route the effects of
US Brand Name
- Naglazyme
Descriptions
Galsulfase injection is used to treat symptoms of an inherited disease called mucopolysaccharidosis (MPS VI) disease or Maroteaux-Lamy syndrome. This medicine improves walking and stair-climbing ability in patients who are lacking a certain enzyme called N-acetylgalactosamine 4-sulfatase in the body.
This medicine is to be given only by or under the direct supervision of a doctor.
This product is available in the following dosage forms:
- Solution
Pediatric
Appropriate studies performed to date have not demonstrated pediatric-specific problems that would limit the usefulness of galsulfase injection in children 5 years of age and older. Your doctor may choose to use this medicine in children younger than 5 years of age at their discretion.
Geriatric
Appropriate studies have not been performed on the relationship of age to the effects of galsulfase injection in the geriatric population. Safety and efficacy have not been established.
Pregnancy
| Pregnancy Category | Explanation | |
|---|---|---|
| All Trimesters | B | Animal studies have revealed no evidence of harm to the fetus, however, there are no adequate studies in pregnant women OR animal studies have shown an adverse effect, but adequate studies in pregnant women have failed to demonstrate a risk to the fetus. |